Treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
AssigneeNsGene A/S
InventorsJesper Roland Jørgensen, Lars Ulrik Wahlberg, Teit E. Johansen
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of Meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain. In a preferred embodiment the disorder to be treated is allodynia, and hyperalgesia, more preferably allodynia including thermal and tactile allodynia.
Claims16
A method of treatment of hyperalgesia in a human subject in need thereof, comprising administering to said subject a therapeutically effective amount of a neurotrophic polypeptide comprising an amino acid sequence that is at least 90% identical to SEQ ID NO:3.
A method of treatment of spontaneous pain in a human subject in need thereof, comprising administering to said subject a therapeutically effective amount of a neurotrophic polypeptide comprising an amino acid sequence that is at least 90% identical to SEQ ID NO:3.
A method of treatment of phantom pain in a human subject in need thereof, comprising administering to said subject a therapeutically effective amount of a neurotrophic polypeptide comprising an amino acid sequence that is at least 90% identical to SEQ ID NO:3.
Dependencies are inferred from the claim text.